Vivani Medical (VANI) Accounts Payables (2014 - 2026)
Vivani Medical (VANI) posted quarterly Accounts Payables of $1.5 million for Q1 2026, up 45.92% year-over-year from $1.0 million in Q1 2025, and up 41.96% quarter-over-quarter from $1.0 million in Q4 2025.
Vivani Medical (VANI) Accounts Payables (2014 - 2026) Analysis & Trends
Vivani Medical's Accounts Payables history runs 13 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 45.92% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 45.92% YoY), while the FY2025 annual figure was $1.0 million, up 26.32% from the prior year.
- Accounts Payables for Q1 2026 stood at $1.5 million, up from $1.0 million in the prior quarter.
- The five-year high for Accounts Payables was $2.0 million in Q2 2023, with the low at $542000.0 in Q4 2023.
- The 5-year median for Accounts Payables is $1.0 million (2025), against an average of $1.2 million.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables jumped 318.86% in 2022, then slumped 67.57% in 2024.
- Vivani Medical's Accounts Payables stood at $1.2 million in 2022, then plunged by 53.95% to $542000.0 in 2023, then soared by 50.74% to $817000.0 in 2024, then rose by 26.32% to $1.0 million in 2025, then surged by 41.96% to $1.5 million in 2026.
- Business Quant data shows VANI's Accounts Payables at $1.5 million in Q1 2026, $1.0 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 817,000.00 |
| Sep 30, 2024 | 815,000.00 |
| Jun 30, 2024 | 645,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 542,000.00 |
| Sep 30, 2023 | 1.89 Mn |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 746,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | 966,000.00 |
| Mar 31, 2022 | 744,000.00 |
| Dec 31, 2021 | 281,000.00 |
| Sep 30, 2021 | 758,000.00 |